Mode
Text Size
Log in / Sign up
N/A N=203 Randomized Treatment

ReActiv8 Stimulation Therapy vs Optimal Medical Management: A Randomized Evaluation

Chronic Low-back Pain

Enrolled (actual)
203
Serious AEs
3.9%
Results posted
Apr 2025
Primary outcome: Primary: Change in Oswestry Disability Index (ODI) — -19.7; -2.9 units on a scale — p=<0.001

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
ReActiv8 (Device)
Age
Adult, Older Adult · 21+ yrs
Sex
All
Sponsor
Mainstay Medical
Primary completion
Sep 2024

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Oswestry Disability Index (ODI)
-19.7; -2.9 <0.001 sig
SECONDARY
Change in Low Back Pain Numerical Rating Scale (LBP NRS)
-3.6; -0.6 <0.001 sig
SECONDARY
Change in EQ-5D
0.155; 0.008 <0.001 sig

Summary

This study is a prospective, randomized study comparing ReActiv8 Therapy to Optimal Medical Management (OMM).

Eligibility Criteria

Inclusion Criteria

  • Age ≥21 years
  • Evidence of lumbar multifidus muscle dysfunction
  • Intractable Chronic Low Back Pain that has persisted >6 months resulting in pain most of the days in the past 12 months
  • Failed therapy including pain medications and physical therapy
  • Not a candidate for spine surgery
  • Low Back Pain NRS of ≥6 and ≤9
  • Oswestry Disability Index score ≥30 and ≤60
  • Willing and capable of giving Informed Consent
  • Able to comply with this protocol
  • On Optimal Medical Management per the Investigator

Exclusion Criteria

  • Contraindicated for the ReActiv8 System
  • BMI > 35
  • Any surgical correction procedure for scoliosis at any time, or a current clinical diagnosis of moderate to severe scoliosis
  • An independent MRI assessment identifying a pathology that is likely the cause of the CLBP and is amenable to surgery
  • Leg pain described as being worse than back pain, or radiculopathy (neuropathic pain) below the knee
  • Any condition unrelated to CLBP which, in the opinion of the Investigator, could limit physical movement or compliance with the protocol, or interfere with the assessment of efficacy
  • Surgical and other procedure exclusions
  • Psycho-social exclusions
  • Protocol compliance exclusions
  • General exclusions
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04803214). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search